AUS
NZ
UK
CA
USA
IND
Healthcare
Orthocell (ASX:OCC) Marks Key Milestone with First Sales of Remplir™ in Singapore
December 16, 2024 01:44 PM AEDT| By Team Kalkine MediaHighlights,Orthocell,(OCC) achieves initial sales of,Remplir,™ in Singapore,.,Expansion into Singapore positions the product in the ASEAN region's nerve repair market,.,Regulatory filings for US FDA clearance set to accelerate growth globally,.,Ortho...
Control Bionics Expands NeuroStrip Technology into US and Japanese Markets
December 16, 2024 12:48 PM AEDT| By Team Kalkine MediaHighlights,Control Bionics (CBL) enters US sports and Japanese rehabilitation sectors with,NeuroStrip,agreements,.,Strategic partnerships target enhanced athletic performance and neurological recovery,.,New deals expected to generate revenue through...
INOVIQ's Early-Stage Success in Targeting Breast Cancer with Exosomes
December 16, 2024 12:18 PM AEDT| By Team Kalkine MediaHighlight:,INOVIQ Ltd (,ASX:IIQ,) reports initial success in using exosomes from natural killer (NK) cells to target and kill breast cancer cells in vitro.,Exosomes,,proteins,and DNA carrying nanoparticles, are engineered with chimeric antigen recept...
Invex Reports Promising Results in Alzheimer’s Simulation Using Exenatide
December 16, 2024 12:11 PM AEDT| By Team Kalkine MediaHighlights,Exenatide's Role in Alzheimer's Simulation,:,Invex,Therapeutics has successfully tested exenatide, a diabetes drug, in a 3D human brain model to assess its potential in delaying Alzheimer’s disease (AD). This marks the first demonstration...
Acrux Secures Fourth FDA Approval for Nitroglycerin Ointment, Advancing U.S. Commercialisation
December 13, 2024 03:15 PM AEDT| By Team Kalkine MediaHighlights:,FDA Approval and Commercialisation:,Acrux Ltd (ASX: ACR) receives FDA approval for,Nitroglycerin,Ointment 0.4%, a topical treatment for chronic anal fissures, enabling U.S. commercialisation through licensee,TruPharma,.,Market Potential:,...
Nova Eye Medical (ASX:EYE) Positioned for a Profitable Turnaround
December 13, 2024 12:38 PM AEDT| By Team Kalkine MediaHighlights,Nova Eye Medical (EYE) is targeting profitability within a short timeframe,.,Analysts predict significant growth for the glaucoma treatment innovator,.,The company,operates,debt-free, reducing financial risk,.,Nova Eye Medical (ASX:EYE), a...
Breakthrough in Head and Neck Cancer Treatment by Immutep
December 12, 2024 03:27 PM AEDT| By Team Kalkine MediaHighlights,Immutep (IMM) shares data from its Phase IIb TACTI-003 trial.,Promising results in treating head and neck squamous cell carcinoma (HNSCC).,Combination therapy shows significant improvement in survival rates.,Immutep (ASX:IMM) has revealed...
Orthocell (ASX:OCC) Achieves Early Sales of Nerve Repair Product in Singapore
December 12, 2024 03:20 PM AEDT| By Team Kalkine MediaHighlights,Orthocell,(OCC) marks its first sales of,Remplir,in Singapore,.,Remplir,supports nerve healing with its collagen-based design,.,Early success achieved ahead of its,anticipated,2025 launch,.,Orthocell (ASX:OCC), a leading regenerative medic...
Immutep Ltd (ASX: IMM) Soars on Positive Clinical Trial Results, Shares Up 6%
December 12, 2024 01:42 PM AEDT| By Team Kalkine MediaHighlights,Immutep Ltd sees a sharp rise in share price after announcing promising results from TACTI-003 Phase IIb trial.,The trial’s positive outcomes for head and neck cancer treatment fuel investor optimism.,CEO Marc Voigt highlights the potentia...
LTR Pharma Launches Online Men's Health Platform
December 12, 2024 12:52 PM AEDT| By Team Kalkine MediaHighlights:,Launch of SPONTAN,:,LTR Pharma (,ASX:LTP,) has introduced an online men’s health platform to,facilitate,the regulated prescription of its nasal spray Viagra product, SPONTAN.,Market Response,:,Despite,initial,enthusiasm, the company's sha...
Orthocell Ltd (ASX:OCC) Makes Breakthrough with First Remplir™ Sales in Singapore
December 12, 2024 12:05 PM AEDT| By Team Kalkine MediaHighlights,Orthocell,Ltd (OCC) achieves first sales of,Remplir,™ in Singapore.,Remplir,™ is now sold in Singapore, Australia, and New Zealand.,Sales and surgeon endorsements of,Remplir,™ are growing.,Orthocell Ltd (ASX:OCC), a leader in regenerative...
SDI Limited (ASX:SDI) Demonstrates Strong Trends in Return on Capital
December 12, 2024 11:59 AM AEDT| By Team Kalkine MediaHighlights,SDI Limited (SDI) shows increasing return on capital employed (ROCE).,The company's capital employed has grown by 52% in the last five years.,SDI Limited has provided a 65% return to shareholders over five years.,SDI Limited (ASX:SDI) is e...
Sigma Healthcare (ASX: SIG) Shares Rise on Merger Update with Chemist Warehouse
December 11, 2024 04:12 PM AEDT| By Team Kalkine MediaHighlights,Sigma Healthcare shares up 1.5%, now up almost 190% YTD.,Investors respond to update on merger progress with Chemist Warehouse.,Merger expected to be implemented in February 2025, with approval conditions remaining.,Sigma Healthcare Ltd (A...
CSL Limited (ASX:CSL): Strong Fundamentals, But Earnings Growth Remains a Concern
December 11, 2024 01:58 PM AEDT| By Team Kalkine MediaHighlights,CSL Limited (CSL) has seen a recent decline in share value despite decent fundamentals,.,Return on equity (ROE),indicates,profitability but does not align with CSL’s low earnings growth,.,Dividends,remain,consistent, but reinvestment effic...
Syntara’s (ASX:SNT) SNT-5505 Trial Marks Progress in Myelofibrosis Treatment
December 10, 2024 05:35 PM AEDT| By Team Kalkine MediaHighlights,Interim trial data for SNT-5505 shows promising results for Syntara (SNT).,Improvements observed in symptoms and spleen volume among patients.,The drug shows strong tolerability and potential long-term benefits.,Syntara Ltd (ASX:SNT) has a...
What’s Ahead for ResMed (ASX: RMD) Stock in 2025?
December 10, 2024 03:07 PM AEDT| By Team Kalkine MediaHighlights,ResMed's projected 20.2% earnings growth outpaces the industry average of 15.9%.,The company boasts impressive 18.1% year-over-year cash flow growth.,Growth stocks are often the focal point of investors looking for exceptional returns, as...
Anteris Technologies (ASX:AVR) Subsidiary ATGC Debuts on Nasdaq with US IPO
December 10, 2024 11:27 AM AEDT| By Team Kalkine MediaHighlights,Anteris,subsidiary launches IPO for Nasdaq listing,.,Proceeds,to fund heart valve development and global studies,.,Maintains,connection to Australian roots via dual listing,.,Anteris Technologies (ASX:AVR), an Australian-based leader in st...
Visioneering Technologies Announces Voluntary Delisting from ASX
December 10, 2024 11:19 AM AEDT| By Team Kalkine MediaHighlights:,Visioneering Delists After Seven Years,Visioneering Technologies (,ASX:VTI,), a US-based eyecare company, will voluntarily delist from the Australian Securities Exchange (ASX) after seven years of offering Chess Depository Interests (CDIs...
Sonic Healthcare Boosts European Presence with German Laboratory Acquisition
December 09, 2024 01:51 PM AEDT| By Team Kalkine MediaHighlights,Sonic Healthcare (SHL) to acquire Laboratory Group Dr. Kramer & Colleagues in Germany.,Deal valued at €423 million, combining cash payment and share issuance.,Acquisition strengthens Sonic's footprint in Germany and Europe.,Sonic Healthcar...
Terragen Holdings Sees Share Price Surge Following Successful Equity Raising
December 09, 2024 11:55 AM AEDT| By Team Kalkine MediaHighlights,Share Price Surge,: Terragen Holdings experienced a,38.9% jump,in its share price, reaching,5 cents,during early trading hours on December 9, 2024.,Equity Raising Success,: The company successfully raised,$4.76 million,in gross proceeds fr...
Advertise your brand on Kalkine Media